Nycomed US Inc. today announced the appointment of Steve Andrzejewski as the new Chief Executive Officer. He assumes immediate responsibility for Nycomed US Inc., including manufacturing in Melville and Hicksville, New York, distribution and commercial operations for the three marketing and sales divisions Fougera, PharmaDerm and Savage Laboratories.
Steve Andrzejewski has been working in the pharmaceutical and healthcare industry for more than 20 years. He joins from King Pharmaceuticals where he served as Corporate Head, Commercial Operations first and then as Chief Commercial Officer.
He holds a Bachelor's degree in Psychology from Hamilton College in New York, and an MBA in Finance/International Business from New York University. Steve Andrzejewski began his career as a sales representative at Schering-Plough Corporation, and rose steadily through the ranks over the next 16 years. From 1998 on he held a number of Vice President positions at Schering-Plough, including Marketing and New Products. Before joining King Pharmaceuticals, he was the Senior Vice President of the Commercial Business at Endo Pharmaceuticals.
"I am delighted to welcome Steve Andrzejewski as our new Chief Executive Officer for Nycomed's US business," says Hakan Bjorklund, Chief Executive Officer of Nycomed. "His experience with both generics and proprietary products will be great assets to guide Nycomed US through the challenging and changing business environment."